Astrana Health (ASTH) Set to Announce Earnings on Tuesday

Astrana Health (NASDAQ:ASTH - Get Free Report) is scheduled to be releasing its earnings data after the market closes on Tuesday, May 7th. Analysts expect Astrana Health to post earnings of $0.32 per share for the quarter. Astrana Health has set its FY24 guidance at $1.28-$1.52 EPS and its FY 2024 guidance at 1.280-1.520 EPS.Persons that are interested in registering for the company's earnings conference call can do so using this link.

Astrana Health (NASDAQ:ASTH - Get Free Report) last posted its quarterly earnings data on Tuesday, February 27th. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.09. The company had revenue of $353.00 million during the quarter, compared to analysts' expectations of $341.17 million. Astrana Health had a return on equity of 11.52% and a net margin of 4.49%. Astrana Health's revenue for the quarter was up 20.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.02 earnings per share. On average, analysts expect Astrana Health to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Astrana Health Trading Up 0.3 %

Shares of ASTH stock traded up $0.10 on Wednesday, hitting $37.25. 121,602 shares of the stock were exchanged, compared to its average volume of 155,913. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.11 and a quick ratio of 2.11. The stock has a market cap of $2.09 billion, a price-to-earnings ratio of 28.22, a P/E/G ratio of 1.24 and a beta of 1.09. The business has a 50-day moving average of $40.70. Astrana Health has a fifty-two week low of $28.86 and a fifty-two week high of $45.71.

Analysts Set New Price Targets

Several brokerages recently commented on ASTH. Truist Financial increased their price target on Astrana Health from $41.00 to $44.00 and gave the company a "hold" rating in a research report on Friday, March 1st. Jefferies Financial Group began coverage on Astrana Health in a research report on Monday, February 26th. They set a "buy" rating and a $50.00 price target for the company.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.